Viking Therapeutics is viewed as a long-term rival to Eli Li...

Viking Therapeutics is viewed as a long-term rival to Eli Lilly and Novo Nordisk in the weight-loss drug market. The rising share price makes it a costly acquisition prospect. The entry of competitors could potentially lower medicine costs, relieving the U.S. healthcare system's financial strain.